Seller record · Research vendor

Loti Labs

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician, prescriber or medical reviewer is named or claimed, and the site directs the reader to seek a healthcare provider elsewhere. 3 more criteria also fail; see the table below.

At a glance

Loti LabsResearch vendor

4/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: research peptides supplied as lyophilized powder, research liquids, and 1 more
FDA letters: None on file

Visit Loti Labs See all eight dispositions

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller that states it manufactures and tests in the United States. Every page is covered by a non-dismissible modal headed Login Required, so a visitor without an account cannot read the catalog, the prices or the policies.

Operating entity No legal entity name for the operator is printed in the footer of every page, the contact page, the terms and conditions page or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Loti Labs' BPC-157 product page
S2	Prescription gating	FAIL	Loti Labs' cart
S3	Pharmacy identification	FAIL	Loti Labs' terms
S4	Compounding disclosure	PASS	Loti Labs' website
S5	Analytical documentation	PASS	Loti Labs' posted image
S6	Business address	PASS	Loti Labs' contact page
S7	Price disclosure	FAIL	Loti Labs' BPC-157 product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician, prescriber or medical reviewer is named or claimed, and the site directs the reader to seek a healthcare provider elsewhere.Source: Loti Labs' BPC-157 product page.

S2FAILAn account wall is the only stop, and its sole qualifying step is a self-certified age and researcher declaration.Source: Loti Labs' cart.

S3FAILThe terms state that Loti Labs is not a compounding pharmacy and not an outsourcing facility, and no pharmacy is named.Source: Loti Labs' terms.

S4PASSThe seller offers no compounded drug and labels every product research use only with an explicit Food and Drug Administration disclaimer.Source: Loti Labs' website.

S5PASSA dated per-lot certificate of analysis for BPC-157 reports 99.9 percent purity by reversed-phase HPLC from Bioviridian Inc, reachable as a public file with no login.Source: Loti Labs' posted image.

S6PASSThe contact page prints a numbered street address in Brooksville, Florida under the trade name Loti Labs.Source: Loti Labs' contact page.

S7FAILEvery price on the site sits behind a non-dismissible login modal that a visitor without an account cannot pass.Source: Loti Labs' BPC-157 product page.

S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides supplied as lyophilized powder, research liquids, capsules.

Visit Loti Labs

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.